Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions
Despite the many prospective randomized trials that have been available in the past decade regarding the optimization of radiation, hormonal, and surgical therapies for high-risk prostate cancer (PCa), many questions remain. There is currently a lack of level I evidence regarding the relative effica...
Main Authors: | Benjamin A. Greenberger, Victor E. Chen, Robert B. Den |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01273/full |
Similar Items
-
The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
by: Jongchan Kim, et al.
Published: (2017-09-01) -
Radical prostatectomy for high-risk prostate cancer | Opinion: NO
by: Saum Ghodoussipour, et al. -
Early stage prostate cancer: biochemical recurrence after treatment
by: Danielle A. Zanatta, et al.
Published: (2014-04-01) -
Radical prostatectomy for high-risk prostate cancer | Opinion: YES
by: Leonardo O. Reis, et al. -
Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
by: Gustavo Arruda Viani, et al.